Finally, the development of new acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors represents a viable approach to alleviate Alzheimer’s disease [31]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.